Company page

Illumina, Inc.

Illumina, Inc. is a leading company in the field of genomics, specializing in DNA sequencing and array-based solutions. Based in the United States, Illumina has a market capitalization of approximately $29.37 billion. The company focuses on advancing the understanding of genetics and improving healthcare through innovative technologies.

ILMN:NASDAQUpdated July 24, 2026
Illumina, Inc. logo
Ticker
ILMN:NASDAQ
Asset type
Stock
Market cap
$29.37B
Sector
Health Technology
Industry
Medical Specialties
Exchange
NASDAQ
Currency
USD